{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:13:06Z","timestamp":1793387586081,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10517-025-06408-9","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T17:14:20Z","timestamp":1748625260000},"page":"739-743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and Immunogenic Efficacy of Inactivated Monovalent Vaccines against Newcastle Disease in the Republic of Kazakhstan"],"prefix":"10.1007","volume":"178","author":[{"given":"N. Zh.","family":"Akmyrzayev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. N.","family":"Assanzhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zh.K.","family":"Kydyrbayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sh.Zh.","family":"Ryskeldinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. T.","family":"Zhunushov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye.M.","family":"Kozhamkulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Mailybayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Sagymbayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye.T.","family":"Myrzakhmetov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"4","key":"6408_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/03079457409353840","volume":"3","author":"DJ Alexander","year":"1974","unstructured":"Alexander DJ, Allan WH. Newcastle disease virus pathotypes. Avian Pathol. 1974;3(4):269-78. https:\/\/doi.org\/10.1080\/03079457409353840","journal-title":"Avian Pathol."},{"key":"6408_CR2","doi-asserted-by":"publisher","unstructured":"Alexander DJ. Newcastle disease virus \u2013 an avian Paramyxovirus. Newcastle Disease Boston, 1998. P. 11-20. https:\/\/doi.org\/10.1007\/978-1-4613-1759-3_2","DOI":"10.1007\/978-1-4613-1759-3_2"},{"key":"6408_CR3","unstructured":"Myrzakhmetov YeT, Sazykulova GD, Assanzhanova NN, et al. Optimization of inactivation parameters Newcastle disease virus. Izv Nats Akad Nauk Kyrgyz Rep. 2024;(1):21-9. Russian."},{"key":"6408_CR4","unstructured":"Newcastle disease. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Mammals, Birds and Bees. OIE, 2008. Vol. 1. P. 576-89."},{"key":"6408_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.vetmic.2016.12.019","volume":"206","author":"KM Dimitrov","year":"2017","unstructured":"Dimitrov KM, Afonso CL, Yu Q, et al. Newcastle disease vaccines-A solved problem or a continuous challenge? Vet Microbiol. 2017;206:126-36. https:\/\/doi.org\/10.1016\/j.vetmic.2016.12.019","journal-title":"Vet Microbiol."},{"issue":"4","key":"6408_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.dci.2013.06.007","volume":"41","author":"PJ Miller","year":"2013","unstructured":"Miller PJ, Afonso CL, El Attrache J, et al. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses. Dev Comp Immunol. 2013;41(4):505-13. https:\/\/doi.org\/10.1016\/j.dci.2013.06.007","journal-title":"Dev Comp Immunol."},{"key":"6408_CR7","unstructured":"Newcastle disease vaccine (inactivated). European Pharmacopoeia. Strasbourg, 2008. P. 937-39."},{"issue":"1","key":"6408_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00253-019-10106-8","volume":"104","author":"Z Hongzhuan","year":"2020","unstructured":"Hongzhuan Z, Ying T, Xia S, et al. Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy. Appl Microbiol Biotechnol. 2020;104(1):107-17. https:\/\/doi.org\/10.1007\/s00253-019-10106-8","journal-title":"Appl Microbiol Biotechnol."},{"issue":"4","key":"6408_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/03079457409353838","volume":"3","author":"D Cessi","year":"1974","unstructured":"Cessi D, Nardelli L. Vaccination against Newcastle disease: efficacy of an oil emulsion vaccine. Avian Pathol. 1974;3(4):247-53. https:\/\/doi.org\/10.1080\/03079457409353838","journal-title":"Avian Pathol."},{"issue":"1","key":"6408_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.56808\/2985-1130.2160","volume":"39","author":"W Wanasawaeng","year":"2009","unstructured":"Wanasawaeng W, Tawatsin A, Sasipreeyajan J, et al. Development of inactivated Newcastle disease vaccine using palm oil as an adjuvant. Thai J Vet Med. 2009;39(1):9-16.","journal-title":"Thai J Vet Med."},{"key":"6408_CR11","doi-asserted-by":"publisher","unstructured":"Radmehri M, Talebi A, Ameghi Roudsari A, et al. Comparative study on the efficacy of MF 59, ISA70 VG, and nano-aluminum hydroxide adjuvants, alone and with nano-selenium on humoral immunity induced by a bivalent Newcastle + avian influenza vaccine in chickens. Arch Razi Inst. 2021;76(5):1213-20. https:\/\/doi.org\/10.22092\/ari.2021.356666.1887","DOI":"10.22092\/ari.2021.356666.1887"},{"issue":"1","key":"6408_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3109\/21691401.2015.1129626","volume":"45","author":"M Jafari","year":"2017","unstructured":"Jafari M, Moghaddam Pour M, Taghizadeh M, et al. Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens. Artif Cells Nanomed Biotechnol. 2017;45(1):84-9. https:\/\/doi.org\/10.3109\/21691401.2015.1129626","journal-title":"Artif Cells Nanomed Biotechnol."},{"key":"6408_CR13","doi-asserted-by":"publisher","unstructured":"Cahyani JI, Widyarini S, Wibowo MH. Comparative safety and efficacy of two bivalent vaccines containing Newcastle disease LaSota and avian influenza H9N2 Sidrap isolate formulated with different oil adjuvants. Vet World. 2020;13(11):2493-501. https:\/\/doi.org\/10.14202\/vetworld.2020.2493-2501","DOI":"10.14202\/vetworld.2020.2493-2501"},{"key":"6408_CR14","doi-asserted-by":"publisher","unstructured":"Chegrynets AI, Saliy OO, Sobko IA, et al. Immunological evaluation of inactivated Newcastle disease vaccine depending on adjuvant composition. Reg Mech Biosystems. 2021;12(3):490-7. https:\/\/doi.org\/10.15421\/022167","DOI":"10.15421\/022167"},{"key":"6408_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/1743-422X-8-321","volume":"8","author":"CG Liu","year":"2011","unstructured":"Liu CG, Liu M, Liu F, et al. Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks. Virol J. 2011;8:321. https:\/\/doi.org\/10.1186\/1743-422X-8-321","journal-title":"Virol J."},{"issue":"26","key":"6408_CR16","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1016\/j.vaccine.2005.01.140","volume":"23","author":"DR Kapczynski","year":"2005","unstructured":"Kapczynski DR, King DJ. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine. 2005;23(26):3424-33. https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.140","journal-title":"Vaccine."},{"issue":"5","key":"6408_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/03079457.2014.951832","volume":"43","author":"T Fentie","year":"2014","unstructured":"Fentie T, Dadi K, Kassa T, et al. Effect of vaccination on transmission characteristics of highly virulent Newcastle disease virus in experimentally infected chickens. Avian Pathol. 2014;43(5):420-6. https:\/\/doi.org\/10.1080\/03079457.2014.951832","journal-title":"Avian Pathol."},{"issue":"1","key":"6408_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1637\/8407-071208-Reg.1","volume":"53","author":"PJ Miller","year":"2009","unstructured":"Miller PJ, Estevez C, Yu Q, et al. Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses. Avian Dis. 2009;53(1):39-49. https:\/\/doi.org\/10.1637\/8407-071208-Reg.1","journal-title":"Avian Dis."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06408-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-025-06408-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06408-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T03:13:54Z","timestamp":1749525234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-025-06408-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6408"],"URL":"https:\/\/doi.org\/10.1007\/s10517-025-06408-9","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}